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B I O C H E M I S T R Y
SirT7 auto-ADP-ribosylation regulates glucose 
starvation response through mH2A1
Nicolás G. Simonet1,2, Joshua K. Thackray3, Berta N. Vazquez1,2,3, Alessandro Ianni4, 
Maria Espinosa-Alcantud1,2, Julia Morales-Sanfrutos5,6, Sarah Hurtado-Bagès7, Eduard Sabidó5,6, 
Marcus Buschbeck7,8, Jay Tischfield3, Carolina De La Torre9,10, Manel Esteller11,12,13,14, 
Thomas Braun4, Mireia Olivella15,16, Lourdes Serrano3,17, Alejandro Vaquero1,2*
Sirtuins are key players of metabolic stress response. Originally described as deacetylases, some sirtuins also exhibit 
poorly understood mono–adenosine 5′-diphosphate (ADP)–ribosyltransferase (mADPRT) activity. We report 
that the deacetylase SirT7 is a dual sirtuin, as it also features auto-mADPRT activity. SirT7 mADPRT occurs at a 
previously undefined active site, and its abrogation alters SirT7 chromatin distribution. We identify an epigenetic 
pathway by which ADP-ribosyl-SirT7 is recognized by the ADP-ribose reader mH2A1.1 under glucose starvation, 
inducing SirT7 relocalization to intergenic regions. SirT7 promotes mH2A1 enrichment in a subset of nearby genes, 
many of them involved in second messenger signaling, resulting in their specific up- or down-regulation. The 
expression profile of these genes under calorie restriction is consistently abrogated in SirT7-deficient mice, resulting 
in impaired activation of autophagy. Our work provides a novel perspective on sirtuin duality and suggests a role 
for SirT7/mH2A1.1 axis in glucose homeostasis and aging.
INTRODUCTION
The members of the Sir2 family, also known as sirtuins, play a key 
role in the response to different types of stress, including metabolic, 
oxidative, and genotoxic stress. Thus, sirtuins are at the crossroads 
of many pathways that control genome stability, metabolic homeo-
stasis, cell cycle control, and apoptosis (1). The family members 
originated in the prokaryotes, where they participated in the metab-
olism of nicotinamide adenine dinucleotide (NAD+). During evolu-
tion, sirtuins have expanded and diversified, acquiring a key role in 
the cross-talk between chromatin and environment. Reflecting this, 
four of the seven mammalian sirtuins (SirT1, SirT2, SirT6, and 
SirT7) have been linked to the control of genome stability at different 
levels (2). One of the most intriguing features of sirtuin biology is that 
they catalyze two NAD+-dependent enzymatic activities: NAD+- 
dependent deacetylation and mono–adenosine 5′-diphosphate (ADP)– 
ribosylation (mADPR), which involves the reversible transfer of one 
ADP-ribose moiety from the coenzyme NAD+ to specific protein 
residues. The former seems to be more prominent among mammalian 
sirtuins since almost all of them are NAD+-dependent protein 
deacetylases, whose activity can, in some cases, target other single 
acyl groups such as butyryl or succinyl, or even long-chain fatty acyl 
groups (3). The relevance of this duality goes beyond sirtuins, as we 
know of just a handful of enzymes, most of them prokaryotic, that 
combine two activities in a single protein (4, 5).
By far, the best studied ADP-ribosyltransferase (ADPRT) is 
poly(ADP-ribose) polymerase 1 (PARP1), which is responsible for 
up to about 90% of the cellular poly-ADP-ribosylation (pADPR) 
generated by DNA damage and is a key pharmacological target for 
the treatment of DNA repair-deficient cancers. In contrast to the 
relatively well studied pADPR, the biological relevance of mADPR 
is more limited. mADPR has been shown to regulate a wide range 
of functions, from cellular stress response upon DNA damage or 
metabolic stress to infectious diseases and cancer (6). Reflecting 
their functional relevance and complexity, there are not only different 
classes of protein-binding modules (readers) that recognize ADP- 
ribosylation but also enzymes involved in the removal of ADP-ribose 
called ADP-ribosylhydrolases (erasers) (6). Among the readers, 
macrodomains are an ancient group of protein domains formed by 
130 to 190 residues present from viruses to humans that bind 
mono(ADP-ribose), poly(ADP-ribose), and NAD+-derived metabolites. 
In humans, at least 12 proteins contain macrodomains belonging to 
four of the six known classes of macrodomains. One of the best 
studied macrodomain-containing proteins is the histone H2A variant 
macroH2A (mH2A). Of the three mH2A isoforms (mH2A1.1, 
mH2A1.2, and mH2A2), only mH2A1.1 has the ability to bind 
ADPR (7). Moreover, mH2A1.1 can also bind free ADP-ribose 
molecules and the product of sirtuin deacetylation, O-acetyl-ADP-
ribose (8), which suggests that mH2A1.1 may play a role as an 
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energetic/metabolic sensor and could be functionally linked to the 
stress response role of sirtuins. mH2A1.1 has been implicated in 
gene repression and activation (9), in the latter case, especially after 
signal-induced gene activation through PARP1 inactivation.
Sirtuin-mediated ADP-ribosylation was described in yeast Sir2p 
before the discovery of the main deacetylation activity (10), and it 
was originally hypothesized that all sirtuins could potentially harbor 
mono-ADPRT (mADPRT) activity (11), although this activity is, in 
most cases, either orders of magnitudes slower than deacetylation 
or simply undetectable in in vitro studies (12). Among mammalian 
sirtuins (SirT1 to SirT7), only two—reported to be weak deacetylase 
enzymes in vitro (13, 14)—are known to ADP-ribosylate other protein 
targets. SirT4-dependent ADP-ribosylation of glutamate dehydro-
genase represses its enzymatic activity by limiting the metabolism 
of glutamate and glutamine to produce adenosine 5′-triphosphate 
(15). SirT6 can mediate the ADP-ribosylation of two targets: PARP1 
under oxidative stress, thereby inducing double-strand break repair 
after DNA damage (16), and KRAB-associated protein-1 (KAP1), to 
promote long interspersed nuclear element–1 (LINE-1) silencing and 
genomic stability (17). SirT6 was also found to auto–ADP-ribosylate 
itself (18), although this activity has not been characterized. In vitro 
kinetic analysis suggests that the deacetylase activity of SirT6 with an 
acetylated H3K9 peptide is about 1000 times weaker than that of other 
sirtuins (14). Both enzymatic activities in SirT6 seem to involve specific 
residues within the same catalytic domain since specific mutations 
in this domain can selectively abrogate either mADPRT or deacety-
lase without altering the other activity (16). The coexistence of the two 
activities in the same protein is uncommon and raises many questions 
about the nature of this duality, the cross-talk between the two activ-
ities, and their specific contribution to the physiological role of sirtuins.
SirT7 is the closest sirtuin to SirT6 and probably one of the least 
studied. Its deficiency has been linked to genome instability and 
several pathologies, including cancer and aging (19, 20). SirT7 is 
involved in active ribosomal DNA (rDNA) transcription (21), DNA 
repair (20), metabolic homeostasis (22), and heterochromatin silenc-
ing and active transcriptional elongation through deacetylation of 
histone H3 lysine 18 (H3K18ac) and histone H3 lysine 36 (H3K36ac), 
respectively (19, 23). Recently, a direct link between SirT7, nuclear 
lamina, and LINE-1 has been described, suggesting a role for SirT7 in 
genome organization (24). SirT7 knockout (KO) mice show severe 
metabolic defects, including resistance to high-fat diet–induced fatty 
liver, obesity, glucose intolerance, and diminished levels of hepatic 
triglycerides and white adipocyte tissue (25, 26). In addition, these 
mice exhibit developmental defects and aging-related phenotypes 
such as perinatal lethality, degenerative heart hypertrophy, osteopenia, 
and kyphosis, and they die significantly younger than their wild-
type (Wt) counterparts (20, 27). While there is a large body of evi-
dence on sirtuin function and longevity, the mechanism by which 
SirT7 controls aging and the relationship between caloric restriction 
response and gene expression programs have not yet been ade-
quately addressed.
Here, we describe how SirT7 harbors an auto-mADPRT activity 
at an alternative catalytic site in addition to its primary catalytic site, 
which is responsible for the deacetylation reaction. Auto-mADPRT 
of SirT7 confers its binding capacity on specific chromatin regions 
through the histone variant mH2A1.1, an interaction that is boosted 
under glucose starvation (GS), which promotes accumulation of 
mH2A1 in a SirT7-dependent manner. To advance our under-
standing of SirT7 function under energy-stress conditions, we 
sought evidence of the key role of the SirT7/mH2A axis in calorie- 
restricted mice. This axis epigenetically regulates the expression of 
genes involved in differentiation, proliferation, metabolism, autophagy, 
and aging pathways. Our functional studies suggest a direct role for 
SirT7 in the control of the stress response through this newly found 
enzymatic activity.
RESULTS
SirT7 is an mADPRT
Several lines of evidence suggest that SirT7 may also harbor mAD-
PRT activity. SirT7 and SirT6 are close homologs with a common 
origin in early eukaryotes. They consistently show a high level 
(42%) of sequence identity and structure in their catalytic core 
domain. SirT7 shares a unique feature with SirT6  in the catalytic 
domain that is different from other mammalian sirtuins (Fig. 1A). 
Whereas there is a large helix bundle in the NAD+-binding Rossmann 
fold in the catalytic region of most sirtuins that connects this domain 
with a small Zn-binding domain, this structure is missing from 
SirT6 and SirT7. This feature was thought to considerably reduce 
the flexibility of the structure, causing the low deacetylase activity 
detected in SirT6 (14). Consistent with this, the in vitro catalytic 
activity of SirT7 with H3K18ac is considerably weaker than that of 
other sirtuins such as SirT1 or SirT2 (23). Considering all this evi-
dence, we aimed to determine whether SirT7 was also a dual sirtuin 
and whether it harbored an ADPRT activity. Our first approach was 
to use an in vitro ADP-ribosylation assay, using [32P]-labeled NAD+ 
to determine whether SirT7 was able to transfer [32P]-ADP-ribose to 
recombinant core histones. The ADPRT reactions of SirT7 on re-
combinant and native histones were very weak, but we detected a 
very efficient incorporation of [32P] in SirT7, strongly suggesting that 
SirT7 is itself a major target of this activity (Fig. 1B and fig. S1A). The 
absence of a smear in the [32P] signal indicated that, as with SirT6, 
SirT7 harbors mADPRT activity (Fig. 1C). This auto-ADPRT activity 
was not altered by mutations previously described as abrogating 
SirT6 ADP-ribosylation activity toward PARP1 and KAP1 (16, 17). 
Mutation of SirT6 G60 to alanine or its equivalent in SirT7 S115 did 
not abrogate this auto-ADPRT activity. Moreover, the same result 
was obtained upon mutation of SirT6 S56 (fig. S1B), which was pre-
viously shown to eliminate both SirT6 activities, or of its equivalent 
in SirT7 S111 (Fig. 1D). In contrast to the close parallelism observed 
between SirT6 and SirT7 ADP-ribosylation activity, SirT7 S111 or 
S115 mutations did not abrogate the deacetylase activity (fig. S1C). 
This result, which was previously reported for S111 (28), suggests 
that the deacetylation active site of SirT6 and SirT7 may be not as 
equivalent as had been proposed previously. Nevertheless, our obser-
vations led us to consider the possibility that sirtuin auto-mADPRT 
activity is not associated with the previously described active site.
SirT7 auto-mADPRT activity depends on the highly conserved 
residues, E185 and N189, present in the ELHGN motif
To define this site, we compared all seven sirtuins at the structural 
level. In contrast to SirT1-5, the lack of the  helix bundle (in cyan; 
Fig. 1E, left) in SirT6 and SirT7 (Fig. 1E, right) induced a reorganiza-
tion in the center of the structure that created a big cavity (Fig. 1E, 
red rectangle), located at the other side of the main catalytic site (in 
red). The cavity contained an ELHGN motif, conserved in the 
SirT6/SirT7 lineage, including the common SirT6/SirT7 ortholog 
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present in the motif, is a key conserved residue among sirtuins in-
volved in the recognition of acetylated substrate in the deacetylation 
activity. While H187 was oriented toward the NAD+-binding pocket 
and the main catalytic site, the two flanking residues, E185 and 
N189, faced in the opposite direction, toward the surface of the cavity 
(Fig. 1G and fig. S1, E and F), forming a loop sustained by the inter-
action of both residues through their side chain. We paid particular 
attention to these two conserved residues because of their possible involve-
ment in the ADP-ribosylation reaction: E185 is the only residue in this motif 
that could initiate the reaction, whereas N189, the only residue in the motif 
conserved exclusively in the whole SirT6/SirT7 lineage (Fig. 1F), could 






































Fig. 1. SirT7 harbors an mADPRT activity that is catalyzed by an alternative domain. (A) Secondary structure of the conserved domain in mammalian sirtuins. Differ-
ences in  helix length between SirT1 to SirT5 and SirT6 to SirT17 are shown in blue. (B) In vitro ADPRT assay of SirT7 purified from human embryonic kidney (HEK) 293F 
cells ± [32P]-NAD+ with purified HeLa core histones. Autoradiography ([32P]-NAD+) and Coomassie blue staining are shown. CBB, Coomassie Brilliant Blue. (C) SirT7 titration 
in ADPRT assay as in (B). (D) Top: Schematic representation of SirT7 and SirT6 proteins tested. Bottom: ADPRT assay performed as in (B) and (C) with the indicated proteins. 
(E) Structural comparison of SirT1 to SirT5 (magenta) and SirT6 and SirT7 (green) conserved domains. The primary catalytic (cat.) site with a bound acetylated peptide is 
shown in red, while the  helix bundle missing in SirT6 and SirT7 is shown in cyan. Loss of this region induces the formation of a cavity in SirT6 and SirT7 (red square). 
(F) Alignment of the sequence present in the cavity in the SirT6 and SirT7 lineage. E185, H187, and N189 are shown in green, blue, and red, respectively. (G) Molecular 
model of the SirT7 catalytic domain based on the crystal structure of SirT6. H187 is oriented toward the NAD+ molecule (orange) and the acetylated substrate (red). E185 
and N189 are located in the same loop as H187 although pointing in the opposite direction. (H and I) In vitro auto-ADPRT assay of SirT7 proteins purified from HEK293F 
cells. (J) Deacetylation and ADPRT activity of the indicated proteins. The mADPRT and deacetylation activities were quantified from assays as in (H) and as in fig. S1H, re-
spectively. For the deacetylation reaction, the indicated proteins were incubated with hyperacetylated core histones purified from HeLa cells and the deacetylation of 
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was confirmed with the finding that the E185N and N189A muta-
tions both abrogated SirT7 auto-mADPRT activity (Fig. 1H).
A highly conservative mutation to glutamine (N189Q) had the 
same effect, suggesting that the lack of activity of the N189 mutant 
was not due to an indirect structural effect (Fig. 1I). The fact that 
N189Q is structurally very similar to the WT protein (fig. S1G) but 
cannot replace glutamine as acceptor of ADP-ribose suggests that 
N189 may play an essential role in the mechanism of ADP-ribosylation. 
N189 mutants were defective in ADPRT activity but still featured 
deacetylase activity, while the H187Y mutant, just two residues 
away, had the completely opposite pattern (Fig. 1J and fig. S1H). 
Considered together, these observations indicate that SirT7 auto- 
mADPRTion is catalyzed at a conserved alternative secondary 
active site located in a previously uncharacterized domain.
N189-dependent auto-mADPRT involves several residues 
distributed around the SirT7 surface and regulates SirT7 
genomic distribution
We also confirmed the conserved role of N189 since the equivalent 
mutation in SirT6 N135 also abrogated SirT6 mADPRT activity 
(Fig. 2A) but did not eliminate its deacetylase activity toward H3K18ac 
(Fig. 2B and fig. S2A). There were two further lines of evidence of 
the importance of N189: First, the N189 mutant was significantly 
less ADP-ribosylated in vivo than was WT SirT7 (Fig. 2C); second, 
mass spectrometry (MS) analysis of SirT7 auto-mADPRTion identified 
eight ADP-ribosylated peptides distributed across the entire surface 
of the SirT7 protein (Fig. 2, D and E; fig. S2, B and C; and table S1). 
All but one of them were undetected in the N189 mutant (Fig. 2E, in 
magenta), confirming a key role for N189 in SirT7 ADPRT. Together, 
these observations strongly suggest that SirT7 auto-mADPRTion is 
catalyzed at an alternative secondary active site.
Taking advantage of our ability to specifically inhibit each of the 
two SirT7 enzymatic activities, we next studied the impact of these 
mutations on SirT7 distribution. Our first step was to study immuno-
fluorescence (IF) signal of WT, H187Y, N189A, and N189Q in SirT7−/− 
mouse embryonic fibroblasts (MEFs). We observed that while H187Y 
had an identical distribution to WT SirT7, whereby it was enriched 
in the nucleolus, the patterns of localization of N189A and N189Q 
were radically different. Both N189 mutants showed a more dispersed 
pattern of distribution that resulted in a loss of nucleolar enrichment 
in around 80% of the observed cells (Fig. 2, F and G). Although we 
observed a mild decrease in the expression of N189 mutants compared 
to SirT7 WT and H187Y, these differences could not account for 
the marked changes observed in the distribution of these proteins 
(Fig. 2H). The altered distribution of these mutants was confirmed 
by biochemical fractionation of cells expressing SirT7- flagged 
mutants into cytoplasm, soluble nuclear fraction (nucleoplasm), and 
chromatin-insoluble fraction (chromatin). As in the IF studies, H187Y 
behaved similarly to WT and was present in similar levels in the 
nucleoplasm. By contrast, N189A-Q mutants were significantly en-
riched in the chromatin fractions and depleted in the nucleoplasm 
(Fig. 2H). Overall, our results suggest that, in contrast to SirT7 deacetylase 
activity, mADPRT activity, and, in particular, N189, plays a key role in 
both SirT7 genomic localization and chromatin-binding dynamics.
SirT7 interacts with the ADP-ribose binding protein 
mH2A1.1 upon GS
We tried to identify SirT7 binding partners to understand the func-
tional link between SirT7 and ADP-ribosylation. We performed 
SirT7 affinity purification in human embryonic kidney (HEK) 293F 
cells and identified potential SirT7 interactors by MS analysis. We 
identified the histone variant mH2A1 from among the candidates 
(Fig. 3A and table S2). mH2A1.1 was the only one of the three 
mH2A isoforms that specifically binds ADP-ribose through its 
macrodomain (Fig. 3B) (7) and interacted specifically with SirT7 
(Fig. 3C). We next examined whether the SirT7-mH2A1.1 interac-
tion depends on SirT7 ADP-ribosylation by incubating bacterially 
expressed recombinant SirT7 (rSirT7) WT or N189A in the presence 
or absence of NAD+ and dialyzing the reaction to remove all remnant 
NAD+ molecules. We tested its ability to specifically pull down mH2A1.1 
from HEK293F nuclear extracts under stringent conditions (Fig. 3D). 
We found that only rSirT7 WT previously incubated with NAD+ 
was able to interact with WT mH2A1.1 under these conditions 
(Fig. 3E). Consistently, while the ADPRT-defective mutant N189A 
was not able to interact in any of these conditions (Fig. 3D), the 
deacetylase mutant H187Y behaved similarly as SirT7 WT (fig. S3A). 
As further evidence that SirT7 auto-mADPRT mediates this binding, 
no interaction was detected under these conditions when we used 
mH2A1.1 G224E (Fig. 3E, lanes 5 and 6), a mutant unable to bind 
specifically to ADP-ribose (7). This is compelling evidence that 
SirT7 auto-mADPRT mediates this binding.
The in vivo interaction between SirT7 and mH2A1.1 was specific 
but weak. Considering the direct link between sirtuins and the stress 
response, we investigated whether the SirT7-mH2A1.1 interaction 
is boosted under specific stress conditions, such as ultraviolet (UV) 
or ionizing irradiation (IR), oxidative stress (H2O2), or GS. Under 
highly stringent conditions, there was a significant increase in the 
interaction between the two factors, specifically upon GS (Fig. 3F), 
which was consistent with the established link between both proteins 
and glucose homeostasis (8, 25). MS analysis of SirT7-FLAG purified 
under these stress conditions identified SirT7 ADP-ribosylation 
under UV, oxidative, and GS conditions but not in the absence of 
stress (C) or under IR [Fig. 3F (bottom), fig. S3, and table S1]. The 
ADP-ribosylation detected under GS and IR had been observed to 
be N189-dependent in our previous experiment (Fig. 2D). This dis-
crepancy between the stress-induced SirT7 ADP-ribosylation and 
binding to mH2A1.1 suggested that while ADP-ribosylation is 
essential for binding to mH2A1.1, other GS-specific signaling may 
be important to drive the interaction. In contrast to normal culture 
conditions [no treatment (NT)], GS consistently induced coelution 
of both factors in high molecular weight fractions (around 1 MDa) 
of gel filtration chromatography analysis (Fig. 3G). This observation 
suggests that both factors may be part of a multiprotein complex 
formed under these conditions. As further evidence of this link, 
SirT7 was able to immunoprecipitate endogenous mH2A1.1 specifically 
under GS (Fig. 3H, lanes 3 and 4), an interaction that was abrogated 
by N189 mutation (Fig. 3H, lanes 4 to 6).
SirT7 binds to distal intergenic regions upon GS 
in an mH2A1-dependent manner
While the levels of total mH2A1 and mH2A1.2 decreased upon GS, 
we observed a consistently specific increase of mH2A1.1 under the 
same conditions, suggesting a direct role for this isoform in the GS 
response (Fig. 4A). Consistently, biochemical fractionation analysis of 
SirT7 also showed a progressive accumulation of SirT7 in chromatin 
fractions upon GS, peaking at 40 hours of treatment (Fig. 4B). We 
chose this specific timing, as we determined experimentally that the 
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GS and that 40 hours was the maximum safe time of GS treatment 
before entering apoptosis. To understand the functional relation-
ship between the two factors under GS, we next studied the distri-
bution of SirT7 and mH2A1 under NT and GS conditions in MEFs. 
Supporting the biochemical fraction results, SirT7 chromatin 
immunoprecipitation sequencing (ChIP-seq) analysis showed that 
GS boosted SirT7 localization to chromatin (Fig. 4C). In the case 








Fig. 2. SirT7 N189-dependent auto–ADP-ribosylation regulates SirT7 distribution and chromatin-binding dynamics. (A) In vitro auto-mADPRT assay as in Fig. 1 
with bacterially expressed rSirT6 WT or N135Q. (B) Deacetylation reaction with the recombinant bacterial SirT6 WT, N135Q, and H133Y incubated with recombinant 
mononucleosomes acetylated in H3K18ac (*P < 0.05). Quantification of three experiments similar to the one shown in fig. S2A. The results are represented relative to WT 
SirT7 activity (100%). (C) ADP-ribosylation levels of SirT7 WT or N189A expressed in HEK293F cells monitored by far Western blot with anti–pan–ADP-ribose binding re-
agent. HDAC, histone deacetylase. (D) Analysis of SirT7 auto-mADPRTion identified by MS. ADP-ribosylated peptides identified in SIRT7 WT or N189A after incubation with 
NAD+ were analyzed using high-energy collisional dissociation (HCD) and electron-transfer/higher-energy collision dissociation fragmentation methods. The most probable 
ADP-ribosylated sites are highlighted in red, as the modification cannot be localized with 100% confidence. Further information is included in table S1 and in Materials 
and Methods. (E) Structural model of the SirT7 catalytic domain indicating localization of the ADP-ribosylated peptides identified in (C). The ADP-ribosylation N189- 
dependent (magenta) and N189-independent (orange) residues, the N189/E185 cavity (blue), and the primary catalytic site bound to acetylated peptide (red) are shown. (F) IF assay 
of the indicated green fluorescent protein (GFP)–tagged SIRT7 proteins expressed in SirT7−/− MEFs. Nucleophosmin (B23) was included as a nucleolar marker. DAPI, 
4′,6-diamidino-2-phenylindole. A representative image of the experiment is shown. Scale bar, 5 m. (G) Quantification of IF experiment in (F), indicating the percentage 
of GFP-positive cells with a regular nucleolar distribution (*P < 0.05). (H) Cellular distribution of SirT7 WT, H187Y (HY), N189A (NA), and N189Q (NQ) in whole-cell extract (WCE), 









Simonet et al., Sci. Adv. 2020; 6 : eaaz2590     24 July 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 16
mH2A1 in Wt cells upon GS compared with NT conditions since 
this effect was abrogated in SirT7-deficient MEFs (Fig. 4D). In 
addition, 72.4% (1711 of 2638) of SirT7-associated genes were also 
enriched by mH2A1. SirT7 accumulated mostly in intergenic regions 
[transcription start site (TSS) ± 50 to 500 kb] rather than in proximal 
promoters (Fig. 4E). Genomic Regions Enrichment of Annotations 
Tool (GREAT) analysis associated these regions with specific genes 
(Fig. 4F and fig. S4), suggesting that the sequences correspond to 
gene regulatory regions. The average distance from these sites to the 
associated genes ranges between 50 and 500 kb upstream or down-
stream of the coding region. Many of the SirT7-associated genes 
mapped by GREAT were associated by Kyoto Encyclopedia of Genes 
and Genomes (KEGG) analysis with cell signaling, the majority of 
which directly or indirectly participate in regulating metabolic 
homeostasis (Fig. 4F).
Confirming our previous results, the recruitment of SirT7 to 
these regions upon GS was mH2A1 dependent since its short hairpin 
RNA (shRNA)–driven down-regulation abrogated SirT7 enrichment 
(Fig. 4G). These results indicate that, upon GS, mH2A1.1 recruits 
SirT7 to the intergenic regions and suggest that SirT7 has a direct 
role in auto-mADPRTion.
The SirT7/mH2A1 regulatory axis regulates the expression 
of a subset of genes upon GS
To clarify the mode of action of SirT7 in the genes regulated by 
SirT7/mH2A1 when they are stressed, we performed RNA sequencing 
(RNA-seq) in Wt and Sirt7−/− MEFs under NT and GS as for the 
ChIP-seq analyses. Of the 1711 mH2A-containing regions occupied 
by SirT7, GS induced the up-regulation and down-regulation of 257 
and 427 nearby genes, respectively, in Wt MEFs (Fig. 5, A and B). 
This up- or down-regulation upon GS was SirT7 dependent in the 
case of 143 and 277 genes, respectively (Fig. 5B). There was an in-
crease in the levels of mH2A1 around these genes upon GS that was 
abrogated in SirT7-deficient cells (Fig. 5C and fig. S5). Among these 
genes, we identified some that encoded growth factors, signaling 
transduction mediators involved in metabolism and differentiation, 
hormone receptors, enzymes, transcription factors, extracellular 
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Fig. 3. SirT7 interacts with mH2A1.1 upon GS in an ADP-ribosylation–dependent manner. (A) Affinity purification of SirT7-binding factors identified the histone H2A 
variant mH2A1 by MS analysis (table S2). HA, hemagglutinin. (B) Schematic representation of the three mH2A isoforms, of which, only mH2A1.1 binds to ADP-ribose (7). 
(C) Endogenous SirT7 specifically immunoprecipitates mH2A1.1 in HEK293F cells. IgG, immunoglobulin G. (D and E) mH2A1.1 recognizes and binds ADP-ribosylated SirT7. 
Immunoprecipitation (IP) of bacterially expressed rSirT7 WT or N189A preincubated ± NAD+ and added to nuclear extracts of HEK293F SirT7 KO cells (CRISPR-Cas9– 
mediated KO of SIRT7) expressing mH2A1.1 WT or G224E, a mutant deficient in ADP-ribose binding. Inputs (I) and elutions (E) are shown. A similar experiment with H187Y 
is shown in fig. S3A. (F) Top: Interaction between endogenous SirT7 and mH2A1.1 under high-stringency conditions upon different types of stress in HEK293 cells. C, un-
treated; IR, 7-gray ionizing irradiation; H2O2, oxidative stress. Western blot of the input and elution of immunoprecipitation experiments with anti-SirT7 antibody under 
these conditions. Bottom: Summary of the ADP-ribosylation events detected by MS in SirT7-FLAG expressed in the same cells and purified under the same stress condi-
tions. Further details are shown in table in fig. S3B and in table S1. (G) Superose 6 gel filtration chromatography of nuclear endogenous proteins from nuclear extracts of 
HEK293F cells under normal cell growth (NT) or upon GS. Fraction numbers and approximate molecular weights (MW) are indicated. Western blot of SirT7 and mH2A1.1 
are shown. (H) High-stringency immunoprecipitation of endogenous mH2A1.1 by WT or N189A SirT7 in HEK293F cells treated under normal conditions or under GS. In-
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associated with the second messenger regulatory system, including the 
Ca+2-dependent pathways and the adenosine 3′,5′-monophosphate 
(cAMP)/adenylate cyclase or guanosine 3′,5′-monophosphate (cGMP)– 
dependent protein kinase signaling pathways. We also identified 
many factors associated with heterotrimeric GTP-binding protein 
(G protein) signaling, such as the G protein–coupled receptor 
signaling pathways, some of which have been linked to regulation 
of cAMP signaling in neural systems. Genes down-regulated upon 
GS were involved in cAMP signaling pathway factors, proliferation, and 
cell differentiation, while up-regulated genes were mainly associated 
with cGMP-dependent protein kinase and Rap1 signaling, metabolism, 
and, to a much lesser extent, cAMP/adenylate cyclase signaling (fig. S6A). 
Among these up- or down-regulated factors that we identified are, 
for instance, the connective tissue growth factor (CTGF), the adenylate 
cyclase regulator adrenoceptor alpha 2A (ADRA2A), the guanylate- 
binding protein 6 (GBP6), the histone deacetylase 9 (HDAC9), the 
calcium- binding signaling protein N-terminal EF-hand calcium 
binding protein 1 (NECAB1), and the transcription factors forkhead 
box protein A2 (FOXA2) and myocyte-specific enhancer factor 2C 
(MEF2C). CTGF was particularly interesting, given its key role in 
differentiation, proliferation, glucose homeostasis, and insulin-like 
growth factor 1 (IGF-1) and transforming growth factor– signal-
ing and its link to calorie restriction (CR) and aging (29).
Reconstitution experiments with SirT7 WT, H187Y, and N189A 
in Sirt7−/− MEFs revealed that both enzymatic activities of SirT7 are 
required to produce the GS-associated expression profile of the tested 
genes, as well as the associated enrichment of mH2A detected in 
these genes upon GS (Fig. 5D). Consistent with a direct role of 
SirT7 in these genes through binding to the distal regulatory re-
gions, we also observed SirT7-dependent H3K36 deacetylation in 
these distal sequences, which was dependent on both catalytic activities 
(fig. S6B). These lines of evidence suggest a link between this 
deacetylation event and mH2A gene enrichment. As mH2A1 was 
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Fig. 4. mH2A1 recruits SirT7 to distal intergenic regions associated with metabolic genes upon GS. (A) Levels of three mH2A isoforms in WCE of NIH3T3 cells trans-
fected with scramble shRNA or mH2A1 shRNA and cultured under normal or GS conditions. (B) Levels of endogenous SirT7 and histone H3 in chromatin and nucleoplasm 
fractions purified from Wt and Sirt7−/− MEFs cultured under normal or GS conditions during the indicated times. (C) Venn diagrams showing the intersection of SIRT7- 
associated genes with mH2A1-enriched genes in Wt cells under NT (top) or GS (bottom). SirT7-associated and mH2A1-enriched genes were derived from GREAT analysis 
(fig. S3B and Materials and Methods). (D) Average enrichment of mH2A1 at all genes in Wt (left) or SirT7−/− MEF (right) cells under NT (black) or GS (red) conditions. Data 
are expressed as the log2 ratio of reads per kilobase of transcript per million mapped reads–normalized ChIP/input signals. (E) Distribution of sites occupied by SirT7 upon 
GS around the TSS by GREAT analysis. The values for each bin from the TSS are shown above each bar (TSS: −5 kb, 5 to 50 kb, 50 to 500 kb, and >500 kb). (F) KEGG cell 
signaling pathways for SirT7-associated genes mapped by GREAT analysis under GS in MEF cells. The signaling pathways were ranked by their combined score provided 
by Enrichr analysis. cGMP-PKG, guanosine 3′,5′-monophosphate–protein kinase G; cAMP, cyclic adenosine 3′,5′-monophosphate; TCA, tricarboxylic acid. (G) SirT7 ChIP-qPCR 
(quantitative polymerase chain reaction) analysis of SirT7 binding sites associated with mH2A1 at distal regions upon shRNA-mediated down-regulation of mH2A1 under 
normal and GS conditions in NIH3T3 cells. The amplified regions (red) and their distance to each gene are indicated in the upper part of each graph. Each SirT7 ChIP was 
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correlation between this mark and mH2A/SirT7 through a global 
unbiased analysis of chromatin state changes from NT to GS condi-
tions in Wt and Sirt7−/− MEFs. We defined four states (U1 to U4), 
depending on the appearance or disappearance of mH2A and/or 
H3K27me3 in these sequences upon GS. We observed a positive 
effect of SirT7 on mH2A recruitment upon GS in up-regulated and 
down-regulated genes when H3K27me3 was not present. In contrast, 





Fig. 5. SirT7 dual activity promotes mH2A1 enrichment in the promoters of associated genes, resulting in transcription up-regulation or down-regulation. 
(A) Heat map showing RNA expression changes relative to NT (as log2 magnitude of difference between GS and NT) conditions in Wt and SirT7-deficient MEFs. (B) Pipeline 
applied to RNA-seq data to filter genes associated with SirT7/mH2A1 in Wt and Sirt7−/− MEF cells treated under GS or NT. The analysis was restricted to genes that (i) were 
associated with SirT7 via GREAT and were mH2A1-enriched, (ii) showed a log2 fold change (FC) of expression between WT-GS and WT-NT >0.6, and (iii) showed a differ-
ence between WT and KO log2 FC (GS versus NT) of >0.3 (table S3). (C) mH2A1 ChIP-seq signals across ctgf, a gene differentially enriched in mH2A1 upon GS in Wt MEFs 
compared with NT. (D) Top: Real-time qPCR (RT-qPCR) analysis of genes regulated by SirT7 upon GS and NT. The expression of SirT7 in SirT7−/− MEFs was rescued by retroviral- 
mediated gene transfer of SirT7 WT, H187Y(HY), N189A(NA), and empty vector (−). SEM from n = 4. Two-tailed t tests (*P < 0.05, **P < 0.01, ***P < 0.005, and ****P < 0.001). 
Bottom: Relative mH2A1 enrichment (GS versus NT) by ChIP-qPCR analysis at specific regions around the TSS of the indicated genes [gbp6, −6 kb; necab1, −3 kb; lair1, 
−27.5 kb; ctgf, +600 base pairs (bp); adra2a, −5 kb; and nrip3, +7 kb]. SEM from n = 3. One-way analysis of variance (ANOVA) (*P <0.05, **P < 0.01, and ***P < 0.005). a.u., 
arbitrary units. (E) Chromatin state transitions induced by GS in Wt and SirT7-deficient cells. The colors of the arrows indicate the frequency (%) of the transition as stated 
in the color scale (right). Bottom right: State map illustrating the specific combination of mH2A1 and/or H3K27me3 in the four chromatin states defined in the analysis. 
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opposite effect on mH2A enrichment (Fig. 5E). These results 
suggest an antagonistic interplay between SirT7 and H3K27me3 in 
determining mH2A enrichment upon metabolic stress (Fig. 5E).
SirT7 dependence on the expression of these genes is 
recapitulated in in vivo mouse models of CR
To confirm the contribution of SirT7 to GS response in vivo, we 
generated a CR model in Wt and Sirt7−/− mice (Fig. 6A) and we 
performed several correlative analyses in the livers of these mice. 
Several evidences supported our previous studies with GS. First, we 
studied the expression of the SirT7/mH2A-associated genes that we 
had identified earlier (Figs. 4 and 5). Consistently, the SirT7-dependent 
expression profile of these genes under CR versus ad libitum (AL) 
fully replicated our results in cell culture with GS versus NT 
(Fig. 6B). Second, as in the case of GS, SirT7 was enriched in chromatin 
of these livers upon CR, in part, because of an up-regulation of the 
levels of SirT7 under these conditions (Fig. 6C). Third, we demon-
strated CR-specific interaction between endogenous SirT7 and 
mH2A1.1 in these livers, further supporting the functional parallelism 
between CR and GS (Fig. 6D). Fourth, trying to understand the 
functional implications of the SirT7-mH2A1 axis under CR condi-
tions, we studied the status of autophagy in these samples, given the 
direct involvement of cAMP, cGMP, and Ca+2-dependent signaling 
in the control of autophagy and its established implication in the 
response to CR and aging (31–33). For that purpose, we analyzed 
the levels of a well-established marker of autophagy, the formation 
of the form II of microtubule-associated protein light chain 3 
(LCIII-2). The rate of formation of LCIII-2 directly indicates the 
rate of autophagosome formation and activity. As expected, in Wt 
animals, we observed an increase of LCIII-2 under CR (Fig. 6E), in 
agreement with an increase in autophagy as a response to CR as has 
been described (33). In contrast, in SirT7-deficient mice, while we 
observed increased rates of autophagy in AL conditions, these 
decreased significantly compared to CR in Wt animals (Fig.  6E). 
Supporting a role for SirT7 in CR-dependent autophagy, we observed 
a similar pattern in Beclin-1 (Fig. 6F), another key marker of auto-
phagy involved in the formation of autophagosomes (33). These 
observations suggest that SirT7 plays a key role, at least in the liver, 
in the control of autophagy in the physiological response to CR con-
ditions. These results provide further evidence of a key role for the 
SirT7/mH2A axis in glucose/CR signaling. Overall, our findings not 
only suggest a key role for SirT7 in aging through gene expression 
regulation of second metabolism signaling but also suggest that this 
role is directly related to CR.
DISCUSSION
We report ADPRT activity in SirT7 and identify a novel ADP- 
ribosylation domain containing the ELHGN motif. The direct link 
between this modification, SirT7 dynamic distribution, and mH2A1 
binding in response to GS provides a functional explanation of 
sirtuin enzymatic duality and suggests a key role for SirT7  in CR 
signaling and aging (Fig. 6C).
The catalytic duality of sirtuins has been widely debated since it 
was hypothesized that all sirtuins may have the ability to transfer 
ADP-ribosyl moieties to target proteins (10, 11). Originally described 
as a potential enzymatic alternative to the main deacylation/
deacetylation activity, it was assumed to act alongside the primary 
activity at the same catalytic site. This perception arose primarily 
because the ADPRT activity of some of the sirtuins tested was con-
siderably weaker and less specific than the deacetylase activity and 
was dependent on the presence of an acetylated peptide (11, 34). 
Moreover, the dependency of this activity on the deacetylation reac-
tion of yeast Sir2 was also reported, suggesting that it may be a side 
effect of primary catalytic deacylation or a technical artifact linked 
to the ability of sirtuins to hydrolyze NAD+ as an intermediate step 
before deacetylation (35). It is of particular note that the vast majority 
of this evidence was based on in vitro ADP-ribosylation assays and 
was not validated by other techniques. In this sense, we report the 
first MS analysis of sirtuin ADPRTion and describe a consistent and 
reproducible pattern of N189-dependent ADPRTion in class IV sirtuins, 
the common lineage of SirT6 and SirT7 from early eukaryotes to 
mammals. We demonstrate not only that the role of the ELHGN 
motif in this activity is a highly conserved one but also that the 
catalytic site is physically separated, being located in a different 
structural domain. Our studies suggest that N189 could play an 
important role as the first acceptor of the ADP-ribose molecule 
generated by E185 before its transfer to the final target. This is sup-
ported by the direct interaction with E185 and the different behavior 
of N189Q compared with WT, despite its close structural similarity 
(fig. S1E). Given the wide distribution of these modified residues 
across the surface of SirT7, the automodification probably involves 
the intramodification of SirT7 oligomeric units within the SirT7 
complex, similar to what has been described for PARP1 (36).
Although auto-ADPRTion had already been described in the early 
studies of sirtuin, its role has never been properly characterized. 
Our report suggests a direct role of this modification in SirT7 global 
distribution and in its chromatin-binding dynamics. PARP1 auto- 
ADPRTion was also proposed to regulate PARP1 chromatin-binding 
dynamics (37). As in the case of SirT7, mH2A1.1 has been also in-
volved in PARP1 recruitment, although in this case, it was linked to 
PARP1 inactivation (38). Although our work has focused on auto- 
ADPRTion, the high degree of conservation within the class IV 
sirtuins and the considerable magnitude of the cavity, which makes 
it able to accommodate a wide range of proteins (Fig. 1E and fig. S1D), 
suggest that this novel domain may target other substrates.
In contrast to what was reported for SirT6-dependent ADPRTion 
of PARP1 and KAP1 (16, 17), SirT6 and SirT7 auto-mADPRTion 
does not depend on any key residues involved in the primary 
deacetylation domain, such as SirT6-S56/SirT7-S111, or SirT7-S115 
(Fig. 1D and fig. S1B). This suggests that there may be two types of 
sirtuin-related ADP-ribosylation events, one that takes place at the 
primary catalytic site and that is probably directly associated with 
the main deacetylation reaction and another that is dependent on 
the ELHGN motif including auto–ADP-ribosylation and modifica-
tion of other protein targets. This hypothesis suggests an interesting 
line of future work to confirm its validity and, thereafter, to define 
the extent and the specific range of substrates associated with each 
of these ADP-ribosylation events.
Another major finding of our work is the first evidence of a 
direct functional relationship between sirtuins and mH2A through 
this ADPR activity. This link is supported by the ability of mH2A1.1 
to bind to the sirtuin product O-acetyl-ADP ribose (8). Although 
we have demonstrated that SirT7 auto-mADPRTion is essential for 
the interaction with mH2A1.1 between factors and the recruitment of 
SirT7 to these genomics sites, our observations suggest that there are 
other factors involved. Thus, while we detected auto-mADPRTion 
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observed a boost in the interaction between SirT7 and mH2A1 
under GS conditions (Fig. 3F and fig. S3B). This suggested that 
there must be other signaling events involved that provide specific 
response under GS. Given the direct implication of stress-dependent 
kinases such as AMP kinase in the regulation of SirT7 exit from the 
nucleolus under energy deprivation conditions (39, 40), we speculate 
that phosphorylation of SirT7 may be also required to allow the ob-
served activation of the SirT7/mH2A1 regulatory axis under these 
conditions. However, we cannot discard that other reported modi-
fications of Sirt7, such as arginine methylation or acetylation, may 
be involved. Future studies should characterize these other signaling 
events involved in SirT7 activation upon GS and determine their 
contribution to the SirT7/mH2A1 functional relationship.
Our results demonstrate that GS triggers SirT7 relocalization 
mainly to distal regulatory regions mediated by mH2A1.1. These 
regions do not appear to be canonical enhancer regions because 
they are not enriched in enhancer-specific histone marks (data not 
shown). In turn, SirT7 promotes increased mH2A1 occupancy levels 
in the nearby gene, which results in the transcriptional activation or 
repression of the gene (Fig. 5). The fact that SirT7 seems to induce 
both up- and down-regulation in these genes suggests that its main 
role in this functional context is to promote mH2A enrichment, 
which, in turn, may regulate positive or negative gene expression.
The analysis of chromatin states suggests that H3K27me3 is 
antagonistic to the interplay between SirT7 and mH2A. This intrigu-
ing observation deserves further study. The mechanism by which 
SirT7 promotes this long-range effect on mH2A enrichment around 
genes is unclear, and it may involve chromatin looping, as it occurs 
in enhancer regions. This possible mechanism is consistent with the 
recently established link between SirT7 and the nuclear lamina and 
chromatin organization (24). Our results suggest that the role of 
SirT7 in these genes requires both enzymatic activities, which fur-
ther highlights the essential role of sirtuin duality in this regulatory 
mechanism. In agreement with this, we detected active deacetylation 
of H3K36 in the distal regulatory regions upon the arrival of SirT7, 
which may favor the mechanism of mH2A enrichment. However, 
our studies also suggest that in addition to this proposed mechanism, 
SirT7 may also regulate the expression of some of these target genes 
independently of the up-regulation of mH2A1. For instance, reexpres-

















Fig. 6. SirT7 and mH2A1 axis plays a key role in CR. (A) Model validation studies in WT and Sirt7−/− mice fed AL or calorie restricted (CR, 30%) for 8 weeks. (B) RT-qPCR 
analysis of the indicated genes in liver samples from Wt and Sirt7−/− mice fed AL or CR. Three animals were analyzed for each condition. Each quantification was generat-
ed from three replicates. Probabilities are those associated with one-way ANOVA (*P < 0.05, **P < 0.01, and ***P < 0.005). (C) Levels of SirT7 in liver samples from Wt and 
Sirt7−/− mice AL and CR after subcellular fractionation. WCE and chromatin fractions are shown. (D) SirT7 immunoprecipitation of mH2A1 in the same liver samples. Inputs 
(I) and elutions (E) are shown. (E) Autophagy activity in the Wt and Sirt7−/− livers under AL or CR monitored by levels of formation of LCIII-2. Left: A representative Western 
blot of n = 5 replicates used in the quantification shown. Right: Quantification of the relative accumulation of LCIII-2 compared to glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) analyzed with a two-tailed t test (*P < 0.05). GAPDH was used as a loading control, as we did not detect a significant alteration of the levels of the protein 
in our conditions (data not shown). (F) Similar analysis (n = 5) of Beclin-1 as in (E). (G) Model proposed for the dual SirT7/mH2A regulatory axis in GS. On the basis of our 
data, we speculate that this axis is also involved in CR and aging. Nutrient stress induces SirT7 auto-mADPRT, which leads to mH2A-dependent recruitment of SirT7 to 
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changes of expression in some of these genes upon GS without altering 
significantly the levels of mH2A1. Although, in the majority of these 
cases, this mH2A1-independent effect seems to be minor, this may 
reflect that both SirT7 enzymatic activities target other proteins in these 
genes. Since SirT7 has been shown to interact with a wide range of 
factors from chromatin enzymes to transcription regulators and target 
histone and nonhistone proteins, the observed effect may be due to a 
different combination of SirT7-associated factors depending on each 
specific gene context. Future studies should define these mechanisms, 
the factors involved, and their functional link to mH2A1.
This study also suggests that the Sirt7/mH2A axis regulates a wide 
range of factors under GS. We were able to correlate the expression 
profile of these genes between GS stress conditions in primary 
MEFs and CR treatment in the livers of these mice. In these sense, 
we observed, as in GS, a SirT7-depenent expression of tested genes 
upon CR, an increased localization of SirT7 in chromatin fractions, 
and a specific CR-dependent binding of SirT7 and mH2A1 in these 
livers (Fig. 6, C and D). Moreover, in agreement with previous studies, 
we detected not only gene expression profile differences associated with 
caloric restriction [e.g., ADRA2A, CTGF, and leukocyte-associated 
immunoglobulin-like receptor 1 (LAIR1)] (41) but also new potential 
markers involved in obesity [nuclear Receptor Interacting Protein 3 
(NRIP3)] (42) and immune response [heparan sulfate-glucosamine 
3-sulfotransferase 4 (HS3ST4) and GBP6] (43). Their stress-dependent 
expression response profile was SirT7 dependent, confirming the 
function of SirT7 as a nutrient sensor in response to calorie-restricted 
diet. The observed overrepresentation of second messenger signaling 
among these factors, particularly that related to calcium-associated sig-
naling, is quite unexpected because it suggests that this is a major 
target of the SirT7/mH2A signaling axis. Considering the wide range 
of general and tissue-specific functions regulated by these pathways, 
the functional relevance of this regulatory axis may extend beyond 
glucose metabolism. cAMP/adenylate cyclase signaling was shown 
to regulate SirT6 activity, which suggests that regulatory feedback 
may operate in this context. SirT7 has been shown to regulate several 
key stress-dependent pathways such as p53, FOXO, Akt, mitogen- 
activated protein kinase, or extracellular signal–regulated kinase, 
among others (27, 44, 45). The fact that the second messenger signal-
ing plays an essential key role in many of these pathways suggests that 
SirT7 regulates these pathways through this SirT7/mH2A1 regulatory 
axis. Our studies suggest that the SirT7/mH2A1 signaling axis is in-
volved in cellular adaptation to glucose deprivation. The studies with 
the CR model and the correlation that we have been able to establish 
between GS model in cell culture and the CR model in mouse lead us 
to speculate that the SirT7/mH2A1 interplay may have an important 
role in physiological short- and long-term adaptation to nutrient depri-
vation. This hypothesis should be further validated in future studies.
Another significant observation of our work is that SirT7 is 
important in the aging-associated changes linked to glucose homeo-
stasis regulation. Although SirT7 was previously associated with 
aging at different levels, from genome stability and structure to 
ribosomal biogenesis and mitochondrial function (20–22, 24), our 
study is the first to establish a link between SirT7 and CR signaling. 
This link is supported by the in vivo metabolic alterations detected 
in SirT7 KO mice, such as reduced IGF-1 plasma levels and hepatic 
steatosis (20, 22). The decreased levels of autophagy observed in 
SirT7-deficient animals upon CR may also point directly to an effect 
on aging given the accelerated aging phenotype observed in SirT7−/− 
mice and that development of mammalian aging has been directly 
associated to a decreased autophagy activity. Under AL conditions, 
loss of SirT7 seems to promote an up-regulation of autophagy 
(Fig. 6, E and F), which may suggest that SirT7 plays an opposite 
role in autophagy in the absence of stress. Many genomic structural 
alterations caused by aging in mouse livers seem to take place in 
regions 50 to 500 kb upstream and downstream of the TSS of genes, 
which resembles the SirT7 binding profile upon GS. Some of the 
factors regulated by SirT7, such as CTGF or FoxA2, have been 
directly implicated in CR signaling and aging (46, 47). Further work 
is required to assess the contribution of these targets to the accelerated 
aging phenotype associated with SirT7. Our work not only offers a 
new insight into sirtuin duality and highlights the crucial role of 
sirtuins in the epigenetic regulation of metabolism and CR signal-
ing but also provides a broader perspective on the dynamics and 
regulation of sirtuin function.
MATERIALS AND METHODS
Animal studies, CR, and studies
For the CR procedure, 8-week-old male Wt and SirT7−/− animals 
(27) were housed in individual cages and randomly allocated into AL 
or CR group. The average of food eaten AL for each mouse was 
determined by weighing the remaining food on a daily basis for 
1 week. The CR regimen was applied by feeding the animals with 
70% of the calculated amount daily for 8 weeks. All animal experiments 
were approved by the institute’s Institutional Animal Care and Use 
Committee and the local authorities (RP Darmstadt, Germany) 
and performed in accordance with the Guide for the Care and Use 
of Laboratory Animals published by the National Institutes of 
Health (NIH).
SirT7 computational molecular model
For in silico SirT7 structural model, an initial homology model was 
constructed for human SirT7 using the coordinates of the determined 
x-ray crystal structure of human SirT6 (Protein Data Bank ID: 5M6F; 
1.87 Å resolution, 42% of sequence identity). Modeller 9.12 was 
used to model the nondetermined regions of the protein. The side 
chain conformations for nonconserved residues were positioned 
according to SCWRL4 (Krivov). The protein was embedded in a 
TIP3P water box. The initial system was energy-minimized and 
subjected to 10 ns of molecular dynamics equilibration and, lastly, 
to a production stage extending to 150 ns. All the simulations were 
performed with GROMACS 5.0 simulation package. The molecular 
model of SirT7 was used as the initial model to introduce H187Y 
and N189A mutations. For comparison purposes, SirT1 to SirT5 
structures were superimposed to SirT6 structure and SirT7 structural 
model using PyMOL (The PyMOL Molecular Graphics System, 
version 1.8, Schrödinger LLC.).
In vitro enzymatic assays
ADP-ribosylation assays were performed in a total volume of 50 l in 
50 mM tris-HCl (pH 7.8), 1 mM MgCl2, 0.3 mM dithiothreitol (DTT), 
1 M unlabeled NAD+, and 8 Ci of [32P]-NAD+ (800 Ci/mmol; 
PerkinElmer) incubated with 3 to 5 g of recombinant protein from 
Escherichia coli (BL21) or purified from HEK293F cells. The reactions 
were incubated at least for 3 hours at 37°C. Reactions were stopped 
by adding 5× Laemmli sample buffer (supplemented with 10% 
2-mercaptoethanol) to a final concentration of 1× and then separated by 
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proteins were then transferred from gel to PVDF membrane and 
then stained with Coomassie Brilliant Blue (Sigma-Aldrich). The 
incorporation of ADP-ribosylation into proteins was visualized 
by autoradiography.
Deacetylation assays for SirT6 were performed in 50 mM tris-
HCl (pH 8.0), 150 mM NaCl, and 1 mM MgCl2 with 2 mM NAD+ 
(Sigma-Aldrich) in the presence of 3 g of rSirT6 and 1 g of semi-
synthetic recombinant mononucleosomes containing acetyl-lysine 
at position 18 of histone H3 (H3K18ac dNuc, EpiCypher) for 
5 hours at 30°C. In the case of SirT7, reactions were performed in 50 mM 
tris-HCl (pH 7.8), 1 mM MgCl2, and 0.3 mM DTT with 5 mM NAD+ 
with 3 to 5 g of SirT7 and ~0.5 g of hyperacetylated histone sub-
strates for 3 hours at 37°C. The acetylation status was determined 
by Western blot analysis using specific antibodies.
Recombinant protein purification
Human cDNAs of SirT6 or SirT7 were cloned into the pET-30b 
expression vector (Novagen, Germany), containing a hexahistidine 
tag at the C terminus. The constructs were expressed in E. coli BL21 
(DE3) grown at 37°C unit optical density at 600 nm of 0.5 and then 
induced with 1 mM isopropyl--d-thiogalactopyranoside for 4 hours. 
Harvested cells were resuspended in lysis buffer [20 mM Hepes (pH 7.9), 
500 mM NaCl, 10% glycerol, 1 mM EDTA (pH 8.0), 0.1% NP-40, 20 
mM 2-mercaptoetanol, and 1 mM phenylmethylsulfonyl fluoride 
(PMSF)] and lysed by sonication. After centrifugation at 12,000g at 
4°C for 1 hour, the cleared lysates were loaded onto Ni–nitrilotriacetic 
acid agarose resin (Qiagen) by gravity flow. After several washes 
with lysis buffer and BC500 [20 mM tris-HCl (pH 8.0), 500 mM 
KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.1% Nonidet P-40, 
and 0.2 mM PMSF], rSirT7 was eluted using 100 mM imidazole and 
subsequently dialyzed in BC100. Recombinant proteins were then 
kept at −80°C.
Preparation of recombinant histones were performed from E. coli 
Bl21 (DE3) cells as described elsewhere (48). Histone octamers were 
concentrated to 3 to 15 mg/ml, adjusted to 50% (v/v) glycerol, and 
stored at −80°C.
Cells transfections and treatments
MEFs derived from Wt and SirT7 KO mice were generated from 
day 13.5 embryos by standard methods. For retroviral infection of 
primary MEFs and NIH3T3 cells, Platinum-A cells were transiently 
transfected using polyethylenimine. Cells were incubated with 
virus-containing supernatant in the presence of polybrene (8 g/ml). 
In the case of shRNA in NIH3T3 cells, after 48 hours of infection, 
infected cells were selected for 72 hours with puromycin (2.0 g/ml). 
Plasmids encoding mouse shRNAs of mH2A isoforms were obtained 
from Addgene (Cambridge, MA, USA): pSUPER retro puro mH2A1 
shRNA (#30517) and pSUPER retro puro Scr shRNA (#30520). 
HEK293F cells were transiently transfected with plasmids using 3 l of 
polyethylenimine (1 mg/ml) per g of DNA. The following plasmids 
were used for transfection: pcDEF-Flag-SirT7 (WT, H187Y, N189A, 
and N189Q) and pCMV6-SirT7–green fluorescent protein (GFP) 
(OriGene, RG205658).
For GS treatments, MEFs, NIH3T3, and HEK293F cells were 
treated 24 to 40, 12, and 4 hours, respectively, before harvesting 
with glucose-free Dulbecco’s modified Eagle’s medium (Gibco) 
containing 10% dialyzed fetal bovine serum. For oxidative stress, 
cells were treated with 1 mM H2O2 for 1 hour before harvesting. 
Cells were irradiated by exposure in the following conditions: (i) UV 
irradiation at 254 nm (100 J/m2) in a Stratagene Stratalinker 2400 UV 
(Agilent Technologies) and (ii) gamma irradiation delivered using an 
aluminum filter at 100 kV peak in a Faxitron cabinet x-ray system 
(Faxitron Corp.).
Immunoprecipitations and Western blot
Whole-cell proteins and nuclear extracts were prepared according 
to the Dignam protocol. Nuclear extracts were treated with Benzonase 
(Sigma-Aldrich), cOmplete Protease Inhibitor (Roche), and 2 mM 
MgCl2 for 6 hours at 4°C. The lysate was clarified by centrifugation, 
and protein supernatant was incubated with the respective cross- 
linking primary antibody to Protein G Agarose resin (EMD Millipore). 
The cross-linking was performed in 20 mM dimethyl pimelimidate 
(DMP) (Pierce, Thermo Fisher Scientific, MA, USA) dissolved in 
0.2 M sodium borate (pH 9.0). After quenching with 0.2 M ethanol-
amine (pH 8.0), the cross-linked beads with the antibody were stored 
at 4°C in phosphate-buffered saline (PBS) until use. The affinity- 
purified protein complexes from HEK293F cells were gently washed 
at least three time with buffer BC300 [20 mM tris-HCl (pH 8.0) 
300 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.05% Nonidet 
P-40, and 0.1 mM PMSF]. Purification of tagged proteins was done 
at least five times with BC500 [20 mM tris-HCl (pH 8.0) 500 mM 
KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.1% Nonidet P-40, 
and 0.1 mM PMSF] and then eluted either with synthetic peptide 
(0.4 g/ml) from GenScript (Piscataway, NJ, USA) or by acidifica-
tion using a buffer containing 0.2 M glycine (pH 2.3).
Endogenous SirT7 immunoprecipitated from liver tissues were 
performed by using a Polytron homogenizer in ice-cold radio-
immunoprecipitation assay buffer [50 mM tris-HCl (pH 8.0), 150 mM 
NaCl, 1% NP-40, 0.25% sodium deoxycholate, and cOmplete Protease 
Inhibitor (Roche)]. Whole-cell extract was treated with Benzonase 
for 6 hours in 1 mM MgCl2 at 4°C and then sonicated on ice. After 
centrifugation at 17,000g for 5 min at 4°C, protein extracts were in-
cubated with anti-SirT7 cross-linked beads by gently rotating at 4°C 
overnight. After three washes with ice-cold BC350 and 0.075% NP-
40, SirT7 and Sirt7-interacting proteins were eluted from the resin 
with 0.2 M glycine (pH 2.3). Coimmunoprecipitation experiments 
between rSirT7 WT and N189A (preincubated ±NAD+) with nuclear 
extracts from HEK293F SirT7 KO cells (CRISPR-Cas9–mediated 
KO of SIRT7) expressing hemagglutinin (HA)–mH2A1.1 WT or 
G224E were performed in BC300. After three washes with ice-cold 
BC350 and 0.075% NP-40, proteins were eluted from the resin with 
0.2 M glycine (pH 2.3). Densitometric analysis of the Western blots 
was performed with ImageJ software.
The following antibodies were used for Western blotting: anti-Flag 
M2 Antibody (F1804, Sigma-Aldrich), anti-fibrillarin (B-1, Sc-166001, 
Santa Cruz Biotechnology), anti-H3 (#9715, Cell Signaling Technology), 
anti-tubulin (ab-6160, Abcam), anti-glyceraldehyde-3-phosphate 
dehydrogenase (#2118, Cell Signaling Technology), anti-SirT7 (#5360, 
Cell Signaling Technology), anti-SirT7 (sc-365344, Santa Cruz Bio-
technology), anti-mH2A1.1 (D5F6N, Cell Signaling Technology), 
anti-mH2A1.2 (#4827, Cell Signaling Technology), anti-mH2A1 
(ab37264, Abcam), anti-mH2A.2 (gift from M.B.), anti-histone 
H2A (#12349, Cell Signaling Technology), anti-HA (H6908, Sigma- 
Aldrich), anti-myc (#2276, Cell Signaling Technology), anti-H3K18ac 
(#9675, Cell Signaling Technology), anti-H3K27me3 (#9733, Cell 
Signaling Technology), anti-LC3B (L7543, Sigma-Aldrich); anti–
Beclin-1 (#3738, Cell Signaling Technology), and anti–pan–ADP- 
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Subcellular fractionation
To determine the amount of SirT7 proteins in the cytoplasm, nucleo-
plasm, and tight chromatin fraction, NIH3T3 cells were transfected 
with SirT7-HA WT, H187Y, N189Q, and N189A. Cytoplasmic and 
nucleoplasm fraction were obtained with the Dignam protocol ex-
traction (fractions A and C), and the remaining chromatin fraction 
was then solubilized in 1× Laemmli buffer and sonicated with Branson 
250 sonicator.
Preparation of subcellular fractions from the mouse liver tissue 
was prepared by using a Polytron homogenizer in buffer H [20 mM 
tris-HCl (pH 7.4), 0.25 mM sucrose, 3 mM CaCl2, and cOmplete 
Protease Inhibitor]. The nuclei were washed three times by centrifuga-
tion at 300g at 4°C for 5 min. The nuclear pellet was resuspended by 
vortexing for 5 s in buffer C and incubated for 10 min on ice and 
then centrifuged at 17,000g at 4°C for 10 min. The resultant pellet 
considered as the chromatin fraction was solubilized in 1× Laemmli 
buffer and then sonicated, whereas the supernatant was considered 
as the nucleoplasmic fraction.
Mass spectrometric analysis
Protein extracts were precipitated with cold acetone (o/n, −20°C), 
and the protein pellets were resuspended in 20 l of 200 mM 
ammonium bicarbonate with 6 M urea solution. Samples were reduced 
with DTT (10 mM, 30°C, 60 min) and alkylated with chloroacetamide 
(20 mM, 25°C, 30 min). The samples were diluted with NH4HCO3 
to reduce urea concentration below 1 M and digested with trypsin 
(1:10 enzyme:protein, 30°C, 16 hours; Promega). After digestion, 
the peptide mix was acidified with formic acid and then desalted 
with a MicroSpin C18 column (The Nest Group) before liquid 
chromatography–tandem MS (LC-MS/MS) analysis.
The peptide samples were analyzed using a Lumos Orbitrap 
mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) 
coupled to an EASY-nLC 1000 [Thermo Fisher Scientific (Proxeon), 
Odense, Denmark]. Afterward, peptides were loaded directly onto 
the analytical column and were separated by reversed-phase chroma-
tography using a 50-cm column with an inner diameter of 75 m, 
packed with a 2-m C18 particle spectrometer (Thermo Fisher 
Scientific, San Jose, CA, USA) and a binary solvent system of 0.1% 
formic acid in H2O (solvent A) and 0.1% formic acid in acetonitrile 
(solvent B). Chromatographic gradients started at 7% B with a flow 
rate of 300 nl/min and gradually increased to 22% B in 52 min, then 
to 32% B in 8 min, and to 95% B in 10 min. After each analysis, the 
column was washed for 10 min with 95% B.
The acquisition was performed in data-dependent acquisition 
mode, and full MS scans with 1 microscan at a resolution of 120,000 
were used over a mass range of m/z 300 to 1500. Precursor automated 
gain control (AGC) was set to 2 × 105. Charge-state screening was 
enabled, and precursors with +2 to +5 charge states and intensities 
>5 × 104 were selected for MS/MS and fragmented as previously 
described (49).Briefly, precursors that exhibited more than two 
ADP-ribose fragment peak (136,0623, 250,0940, 348,0709, and 428,0372) 
after an initial high-energy collisional dissociation (HCD) fragmen-
tation were submitted to a high-quality HCD fragmentation event 
(acquired in the Orbitrap with collision energy of 35% and a resolu-
tion of 120,000; AGC was set to 5 × 105 isolation window of 2 m/z 
and maximum injection time of 240 ms was used) and an electron- 
transfer/higher-energy collision dissociation MS/MS (the “use-calibrated 
charge-dependent parameter” option was selected, and it was acquired 
in the Orbitrap with a supplementary activation (SA) of 25% and a 
resolution of 120,000; AGC was set to 5 × 105; isolation window of 
2 m/z and maximum injection time of 240 ms were used). Precursors 
masses selected in previous cycle fragmentation were excluded for 
further selection for 60 s, and the exclusion window was set at 10 parts 
per million (ppm). Analysis of SirT6WT/S56A in vitro assays and of 
SirT7 under stress conditions were performed using an Eclipse Orbitrap 
mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) 
coupled to an EASY-nLC 1200 [Thermo Fisher Scientific (Proxeon), 
Odense, Denmark]. See more details in the Supplementary Materials 
related to the chromatography parameters and MS/MS acquisition 
method (Supplementary Materials and Methods).
Acquired spectra were analyzed using the PEAKS X+ software, 
which, as a default, performs de novo peptide sequencing before data-
base searches, to improve the accuracy of the results. The data were 
searched against a Swiss-Prot human database (as of October 2019). 
Trypsin (specific, up to three missed cleavages allowed) was selected for 
database searches, and no enzyme was chosen in de novo searches 
(up to five candidates per spectrum reported). The maximal mass 
error was set to 10 ppm for precursor ions and 0.05 Da for product 
ions. Carbamidomethylation was selected as a fixed modification, 
and methionine oxidation and ADP-ribose (+541.0611 Da at C, D, 
E, H, K, N, Q, R, S, T, and Y) (50) were set as variable modifications. 
The maximal number of modifications per peptide was set to three. 
The false discovery rate was set to 0.05 for peptides.
RNA isolation, cDNA synthesis, and real-time quantitative 
polymerase chain reactions
Total RNA was purified from MEFs and liver using TRIzol reagent 
(Invitrogen, Carlsbad, CA, USA). The cDNA was synthesized from 
5 g of total RNA with a Transcriptor First Strand cDNA Synthesis 
Kit (Roche) according to the manufacturer’s instructions. Real-time 
quantitative polymerase chain reaction (RT-qPCR) was performed 
using the QuantStudio 5 Real-Time PCR System (Thermo Fisher 
Scientific) with SYBR Green PCR Master Mix of Applied Biosystems. 
Relative gene expression was analyzed in QuantStudio 5 software 
(Thermo Fisher Scientific), and values were normalized to the ex-
pression of RNF219 in the case of CR and GS treatments. Details of 
oligonucleotides are shown in table S4.
Site-directed mutagenesis
The different constructs harboring point mutations were cloned by 
site-directed mutagenesis on the basis of the QuikChange protocol 
(Stratagene). The positive clones selected were then verified by 
sequencing using a 3730 DNA Analyzer (Applied Biosystems, 
Foster City, CA, USA).
Immunofluorescence
SirT7−/− cells were fixed with 4% paraformaldehyde for 7 min at 
room temperature and permeabilized for 5 min with buffer A 
[1% bovine serum albumin (BSA) and 0.5% Triton in PBS]. Cells 
were blocked with 1% BSA-PBS solution for 1 hour and further in-
cubated with a rabbit anti-B23 antibody (1:100; Sc-6013-R, Santa 
Cruz Biotechnology) for 1 hour in buffer B (1% BSA and 0.2% Triton 
in PBS). Cells were washed three times 15 min each with PBS and 
stained with an Alexa Fluor 555 fluorophore–conjugated secondary 
antibody (1:200; A27039, Life Technologies). Fluorescence images 
were acquired with a Zeiss 710 confocal module coupled to an Axio 
Observer Z1 equipped with a 63× oil immersion objective. Image 
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ChIP-seq and RNA-seq
For RNA-seq, total RNA from 10-cm dishes containing Wt and 
SirT7 −/− exponentially growing MEFs was harvested using an RNeasy 
miniprep kit (Qiagen) according to the manufacturer’s instructions. 
Samples were sent to the RUCDR, Infinite Biologics sequencing 
center (Rutgers University, NJ, USA) for RNA extraction, library 
preparation (Illumina TruSeq chemistry), and sequencing [2 × 100–base 
pair (bp) paired-end reads, >60 × 106 fragments per sample, Illumi-
na HiSeq in rapid mode]. Reads were demultiplexed, concatenated, 
and delivered as FASTQ files. Raw reads were assessed for quality 
with FastQC. Raw reads were trimmed with Trimmomatic, aligned 
to the University of California Santa Cruz (UCSC) mm9 reference 
genome with HISAT2 (options: --dta), and converted to sorted and 
indexed BAM format with SAMtools. StringTie (in –eB mode) was 
used to estimate transcript abundance using the UCSC mm9 refer-
ence GTF file (obtained from the Illumina iGenomes UCSC mm9 
bundle). Differential expression was analyzed with DESeq2, allow-
ing modeling terms for genotype, treatment, and batch.
ChIP was conducted as described before (20). Briefly, nuclear 
extracts from Wt and SirT7 −/− cells were first obtained, and chromatin 
was prepared by sonication to an average fragment size of 300 bp. 
For SirT7 ChIP, chromatin was diluted eight times in dilution buffer, 
and for macro-H2A and H3K27K3m3 ChIP, chromatin was diluted 
five times. Antibodies were conjugated to beads, and ChIP was con-
ducted overnight at 4°C on a rotator. After washes and reversal of 
cross-links, ChIP libraries were prepared using a ThruPLEX DNA-
seq library preparation kit (Rubicon Genomics) following the 
manufacturer’s protocol. ChIP libraries were then size-selected with 
Pippin Prep (Sage Science) for a final library fragment size of 350 to 
400 bp and quantified with KAPA qPCR. ChIP libraries were then 
sequenced on an Illumina HiSeq 2500 with 2 × 100 or 2 × 75 bp 
paired-end reads to a depth of >20 × 106 fragments per sample at the 
RUCDR, Infinite Biologics sequencing center (Rutgers University, NJ, 
USA). Reads were demultiplexed, concatenated, and delivered as 
FASTQ files.
Raw read quality was first assessed with FastQC version 0.11.3, 
followed by adapter clipping and quality trimming with Trimmomatic 
version 0.36. Reads were then aligned to the mouse (UCSC mm9) 
reference genome with Bowtie with options –n 2 –k 10 and converted 
to BAM format with SAMtools. ChIP, library, and alignment quality 
was evaluated by PCR bottleneck coefficient (PBC), fraction of reads 
in peaks (FRiP), insert size, and strand cross-correlation analysis. 
All samples passed the ENCODE quality standards for ChIP-seq 
studies. Reads per kilobase per million mapped reads–normalized 
signal files were generated from BAM data using deepTools version 
2.4.2 using a bin size of 10 bp.
SirT7 peaks were called in each biological replicate independently 
using MACS version 1.4.2 (--keep-dup auto --bw 450 --pvalue 0.05). 
Reproducibility of individual peaks was assessed with irreproducible 
discovery rate (IDR) (version 2.0.2), and the peaks passing a −log10 
(global IDR) threshold of 1.3 across biological replicates were kept. 
SirT7-associated genes were called using the GREAT tool with 
IDR-passing peaks and the association rule of “Basal plus extension” 
with parameters Proximal = 5.0 kb upstream, 1.0 kb downstream, 
plus Distal up to 10.0 kb, including curated regulatory domains. For 
mH2A1.1 and H3K27me3 ChIP-seq datasets, we used ChromHMM 
to segment the genome into four learned states. First, BAM files for 
ChIP and corresponding INPUT samples were binarized at a resolution 
of 200-bp bins. Binarized data were submitted to the ChromHMM 
LearnModel program and allowed to learn four states. The learned 
model showed posterior enrichment for the following states: U1, no 
enrichment; U2, mH2A1 enrichment; U3, H3K27me3 enrichment; 
and U4, both mH2A1 and H3K27me3 enrichment. mH2A1-enriched 
regions were considered as the union of regions identified as states 
U2 and U4. mH2A1- enriched genes were called using the GREAT 
tool with mH2A1 regions as input with the association rule of “single 
nearest gene” within 10 kb, including curated regulatory domains. 
Chromatin state transitions induced by GS treatment were computed 
relative to NT for each genotype. Briefly, we identified 200-bp bins 
in GS with differing state calls than NT and recorded the initial state 
(that occurring in the NT) and the final state (that occurring in the 
GS). We then took the subset of transition sites at the intersection 
of gene lists (±3 kb upstream and downstream of each gene). We 
quantified transition occupancy by counting the number of base 
pairs occupied by each transition type and normalized this by the 
total number of base pairs that underwent any transition. To ascertain 
the genomic context of these transitions, we submitted each transi-
tion type to the CEAS tool.
Statistical analysis
The represented values show means of at least three or more indepen-
dent experiments (n ≥ 3 with error bars representing SEM unless 
otherwise specified). Data were analyzed using a two-tailed Student’s 
t test (ADP-ribosylation and deacetylation assays and RT-qPCRs 
from rescue experiments in MEFs), and for multiple comparisons 
(RT-qPCRs in mice under caloric restriction), the P value was 
calculated using Microsoft Excel software by two-way analysis of 
variance (ANOVA).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/30/eaaz2590/DC1
View/request a protocol for this paper from Bio-protocol.
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